Nicotinic acid and the prevention of coronary artery disease
JE Digby, JMS Lee, RP Choudhury - Current opinion in lipidology, 2009 - journals.lww.com
JE Digby, JMS Lee, RP Choudhury
Current opinion in lipidology, 2009•journals.lww.comWhether nicotinic acid use becomes routine in the treatment of atherosclerosis is likely to be
determined by the results of two ongoing clinical outcome trials. In addition, further research
is required to explore the 'pleiotropic'effects of nicotinic acid and will ultimately provide a
platform for the development of newer molecules that are potentially beneficial but without
the well known side-effects.
determined by the results of two ongoing clinical outcome trials. In addition, further research
is required to explore the 'pleiotropic'effects of nicotinic acid and will ultimately provide a
platform for the development of newer molecules that are potentially beneficial but without
the well known side-effects.
Summary
Whether nicotinic acid use becomes routine in the treatment of atherosclerosis is likely to be determined by the results of two ongoing clinical outcome trials. In addition, further research is required to explore the ‘pleiotropic’effects of nicotinic acid and will ultimately provide a platform for the development of newer molecules that are potentially beneficial but without the well known side-effects.
Lippincott Williams & Wilkins